Massimo Franchini to Antibodies, Viral
This is a "connection" page, showing publications Massimo Franchini has written about Antibodies, Viral.
Connection Strength
0.446
-
Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma. Clin Chem Lab Med. 2022 01 26; 60(1):e4-e6.
Score: 0.091
-
Lack of cross-reactivity between anti-A IgG isoagglutinins and anti-SARS-CoV-2 IgG antibodies. Clin Chem Lab Med. 2021 Jun 25; 59(7):e279-e281.
Score: 0.088
-
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review. Transfus Apher Sci. 2021 Apr; 60(2):103043.
Score: 0.087
-
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19. Semin Thromb Hemost. 2020 10; 46(7):804-806.
Score: 0.084
-
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
Score: 0.023
-
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma. Transfus Clin Biol. 2022 02; 29(1):101-102.
Score: 0.023
-
Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors. Transfus Apher Sci. 2021 12; 60(6):103216.
Score: 0.023
-
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. Haematologica. 2020 12 01; 105(12):2834-2840.
Score: 0.022
-
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor-recipient differences in concentration of neutralizing antibodies. Clin Microbiol Infect. 2021 Jul; 27(7):987-992.
Score: 0.006